NCT04615104 Pelvic and Acetabular Fracture: A Prospective Observational Study
| NCT ID | NCT04615104 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Wake Forest University Health Sciences |
| Condition | Pelvic Fracture |
| Study Type | OBSERVATIONAL |
| Enrollment | 200 participants |
| Start Date | 2020-01-01 |
| Primary Completion | 2027-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 200 participants in total. It began in 2020-01-01 with a primary completion date of 2027-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The purpose of this study is to understand the trajectory of function and self-reported outcomes of patients following pelvic and acetabular, treated both operatively and nonoperatively.
Eligibility Criteria
Inclusion Criteria: * Fracture of the pelvic ring * Fracture of the acetabulum Exclusion Criteria: * Patients unwilling to provide consent to participate.
Contact & Investigator
Madhav Karunakar, MD
PRINCIPAL INVESTIGATOR
Wake Forest University Health Sciences
Frequently Asked Questions
Who can join the NCT04615104 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Pelvic Fracture. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04615104 currently recruiting?
Yes, NCT04615104 is actively recruiting participants. Contact the research team at Christine.Churchill@advocatehealth.org for enrollment information.
Where is the NCT04615104 trial being conducted?
This trial is being conducted at Charlotte, United States.
Who is sponsoring the NCT04615104 clinical trial?
NCT04615104 is sponsored by Wake Forest University Health Sciences. The principal investigator is Madhav Karunakar, MD at Wake Forest University Health Sciences. The trial plans to enroll 200 participants.